Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

800px-lsd_tabs

First clinical trial for MDMA and LSD combination set to go ahead

August 28, 2020 Medical Communications LSD, MDMA, PTSD

Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …
News
200707-f-zc102-1004

Korea approves Celltrion’s Phase 1 trial of COVID-19 antiviral antibody treatment

August 28, 2020 Medical Communications COVID-19, antibodies, coronavirus vaccine

Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 28, 2020 Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …
News
hamburger-cheeseburger-burger-bun

Obesity increases risk of death from coronavirus and could make vaccines less effective

August 27, 2020 Medical Communications obesity

Obesity can increase the risk of death from coronavirus by nearly 50% and could make a vaccine less effective, according …
News
fifififif

Working Life Interview: Fiona Huzarski, Vice President of Global HR, ADVANZ PHARMA

August 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Working Life, feature

“Every company is different, so you have to be open-minded and receptive to the culture when joining.” Can you briefly …
Feature
800px-unternehmenssitz_janssen-cilag

Janssen granted US approval for multiple myeloma drug combination

August 21, 2020 Medical Communications

The FDA has approved Genmab and Janssen’s Darzalex (daratumumab) as a treatment for relapsed and refractory multiple myeloma, when combined …
News
fda_21_0

FDA approves Novartis’ MS drug Kesimpta for treating relapsed forms of the disease

August 21, 2020 Medical Communications

The FDA has authorised Novartis’ Kesimpta (ofatumumab) for treating patients with relapsing forms of multiple sclerosis (MS), it has been …
News

NICE recommends combination treatment from Roche for certain lymphoma patients

August 21, 2020 Medical Communications FDA, FDA Approval

NICE has moved to recommend Roche’s Polivy (polatuzumab vedotin), when combined with rituximab and bendamustine, for the treatment of diffuse …
News

AstraZeneca scores Japanese approval for Imfinzi combo in extensive-stage small cell lung cancer

August 21, 2020 Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, Japan

AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 21, 2020 Medical Communications COVID-19, coronavirus

The top 10 news stories this week again focus on coronavirus vaccines and treatments, as professor Alexander Chuchalin has quit …
News
fda2outsideweb

FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease

August 14, 2020 Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …
News
fillip

Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine

August 14, 2020 Medical Communications COVID, COVID-19, coronavirus, vaccines

The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …
News
shutterstock_244903099

Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals

August 14, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …
News
vxxxxeer_0

Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine approval

August 14, 2020 Medical Communications

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 14, 2020 Medical Communications COVID-19, coronavirus, pandemic

The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026